Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohanraj Dhanabal

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Endogenous angiogenesis inhibitors as therapeutic agents: historical perspective and future directionMohanraj Dhanabal, Natarajan Sethuraman
Cancer Biology & Therapy|January 11, 2005
Insights into differential endostatin activityTimothy K Maclachlan, Mohanraj Dhanabal
Current Medicinal Chemistry. Anti-Cancer Agents|March 22, 2005
Anti-angiogenic therapy as a cancer treatment paradigmMohanraj Dhanabal, Mike Jeffers, William J Larochelle
Biochemical and Biophysical Research Communications|June 14, 2005
Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic propertiesMohanraj Dhanabal, Michael Jeffers, William J LaRochelle, et al.
The Journal of Biological Chemistry|August 25, 2009
Functional whole-genome analysis identifies Polo-like kinase 2 and poliovirus receptor as essential for neuronal differentiation upstream of the negative regulator alphaB-crystallinCristina Draghetti, Catherine Salvat, Francisca Zanoguera, et al.
Cancer Biology & Therapy|May 27, 2005
Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesisMohanraj Dhanabal, Frank Wu, Enrique Alvarez, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2019
Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonistsYufang Xiao, Srinivasa Karra, Andreas Goutopoulos, et al.
Molecular and Cellular Biology|July 1, 2009
Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrixJuliya Kalinina, Sara A Byron, Helen P Makarenkova, et al.
Cancer Research|July 5, 2002
Angioarrestin: an antiangiogenic protein with tumor-inhibiting propertiesMohanraj Dhanabal, William J LaRochelle, Michael Jeffers, et al.
Molecular Therapy. Nucleic Acids|August 4, 2023
The endosomal escape vehicle platform enhances delivery of oligonucleotides in preclinical models of neuromuscular disordersXiang Li, Mahboubeh Kheirabadi, Patrick G Dougherty, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Endogenous angiogenesis inhibitors as therapeutic agents: historical perspective and future directionMohanraj Dhanabal, Natarajan Sethuraman
Cancer Biology & Therapy|January 11, 2005
Insights into differential endostatin activityTimothy K Maclachlan, Mohanraj Dhanabal
Current Medicinal Chemistry. Anti-Cancer Agents|March 22, 2005
Anti-angiogenic therapy as a cancer treatment paradigmMohanraj Dhanabal, Mike Jeffers, William J Larochelle
Biochemical and Biophysical Research Communications|June 14, 2005
Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic propertiesMohanraj Dhanabal, Michael Jeffers, William J LaRochelle, et al.
The Journal of Biological Chemistry|August 25, 2009
Functional whole-genome analysis identifies Polo-like kinase 2 and poliovirus receptor as essential for neuronal differentiation upstream of the negative regulator alphaB-crystallinCristina Draghetti, Catherine Salvat, Francisca Zanoguera, et al.
Cancer Biology & Therapy|May 27, 2005
Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesisMohanraj Dhanabal, Frank Wu, Enrique Alvarez, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2019
Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonistsYufang Xiao, Srinivasa Karra, Andreas Goutopoulos, et al.
Molecular and Cellular Biology|July 1, 2009
Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrixJuliya Kalinina, Sara A Byron, Helen P Makarenkova, et al.
Cancer Research|July 5, 2002
Angioarrestin: an antiangiogenic protein with tumor-inhibiting propertiesMohanraj Dhanabal, William J LaRochelle, Michael Jeffers, et al.
Molecular Therapy. Nucleic Acids|August 4, 2023
The endosomal escape vehicle platform enhances delivery of oligonucleotides in preclinical models of neuromuscular disordersXiang Li, Mahboubeh Kheirabadi, Patrick G Dougherty, et al.
Pageof 2